Clinical Trial Update: Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating PSA-triggered, individualized management for metastatic hormone-sensitive prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer

Snippet

Sponsor: University of Utah | Conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Phase 2 | Status: RECRUITING